Amgen Inc. v. Sanofi et al
| Delaware District Court | |
| Judge: | Richard G Andrews |
| Case #: | 1:14-cv-01317 |
| Nature of Suit | 830 Property Rights - Patent |
| Cause | 35:145 Patent Infringement |
| Case Filed: | Oct 17, 2014 |
| Re-opened: | Mar 02, 2018 |
| Terminated: | Oct 03, 2019 |
| Last checked: Thursday May 14, 2015 6:23 AM EDT |
|
Defendant
Aventisub LLC
|
Represented By
|
|
Defendant
Regeneron Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Sanofi
|
Represented By
|
|
Defendant
Sanofi-Aventis U.S. LLC
|
Represented By
|
|
Plaintiff
Amgen Inc.
|
Represented By
|
GPO
Oct 20 2015
MEMORANDUM ORDER re: claim construction. Signed by Judge Sue L. Robinson on 10/20/2015. (nmfn) |
|
|
GPO
Jan 29 2016
MEMORANDUM ORDER granting 119 MOTION to Amend/Correct 10 Amended Complaint Plaintiff's Motion for Leave to File a Supplemental and Second Amended Complaint for Patent Infringement and Declaratory Judgment of Patent Infringement filed by Amgen Inc. Signed by Judge Sue L. Robinson on 1/29/2016. (nmfn) |
|
|
GPO
Feb 18 2016
MEMORANDUM ORDER granting in part and denying in part 187 MOTION to Preclude [Amgen's Daubert Motion to Exclude Expert Testimony and Opinion of Dr. Ashley J. Stevens, granting in part and denying in part 185 MOTION to exclude certain expert testimony from plaintiffs on written description and reasonable royalties, granting 191 MOTION to Preclude [Amgen's Daubert Motion to Exclude Testimony on (1) Post-Priority Date Embodiments / Antibodies of the Selected Claims, and (2) Defendants' Expert Opinions as to the Patents' Disclosure of Representative Species]. Signed by Judge Sue L. Robinson on 2/18/2016. (nmfn) (Main Document 226 replaced on 3/3/2016) (nmfn, ). |
|
|
GPO
Mar 02 2016
MEMORANDUM ORDER granting in part and denying in part 231 MOTION for Reargument of the February 18 Memorandum Order Granting Amgen's Daubert Motion Regarding Post-Priority Date Evidence. Signed by Judge Sue L. Robinson on 3/2/2016. (nmfn) |
|
|
GPO
Mar 02 2016
MEMORANDUM ORDER re: evidentiary disputes. Signed by Judge Sue L. Robinson on 3/2/2016. (nmfn) |
|
|
GPO
Mar 07 2016
MEMORANDUM ORDER re: evidentiary disputes. Signed by Judge Sue L. Robinson on 3/7/2016. (nmfn) |
|
|
GPO
Mar 07 2016
MEMORANDUM ORDER re: plaintiffs' evidentiary issues 4 and 13. Signed by Judge Sue L. Robinson on 3/7/2016. (nmfn) |
|
|
GPO
Mar 10 2016
MEMORANDUM ORDER that the relief requested vis a vis plaintiffs' evidentiary issues 10 and 14 is granted in part and denied in part. See Memorandum Order for further details. Signed by Judge Sue L. Robinson on 3/10/2016. (nmfn) |
|
|
GPO
Mar 16 2016
MEMORANDUM ORDER granting 298 MOTION for Judgment as a Matter of Law filed by Regeneron Pharmaceuticals Inc., Aventisub LLC, Sanofi, Sanofi-Aventis U.S. LLC. Signed by Judge Sue L. Robinson on 3/16/2016. (nmfn) |
|
|
GPO
Jan 03 2017
MEMORANDUM OPINION. Signed by Judge Sue L. Robinson on 1/3/2017. (nmfn) |
|
|
GPO
Jan 05 2017
MEMORANDUM ORDER granting 336 MOTION for Permanent Injunction filed by Amgen Inc., Amgen Manufacturing Limited, Amgen USA Inc. Signed by Judge Sue L. Robinson on 1/5/2017. (nmfn) |
|
|
GPO
Jan 09 2017
MEMORANDUM ORDER denying 394 MOTION to Stay Issuance of Permanent Injunction Pending Appeal. The permanent injunction is stayed for 45 days. Signed by Judge Sue L. Robinson on 1/9/2017. (nmfn) |
|
|
GPO
Jan 18 2019
MEMORANDUM OPINION. Signed by Judge Richard G. Andrews on 1/18/2019. (nms) |
|
|
GPO
Feb 08 2019
MEMORANDUM OPINION. Signed by Judge Richard G. Andrews on 2/8/2019. (nms) (Main Document 751 replaced on 2/11/2019) (nms). |
|
|
GPO
Aug 28 2019
MEMORANDUM OPINION. Signed by Judge Richard G. Andrews on 8/28/2019. (nms) |
|
|
GPO
Sep 11 2019
MEMORANDUM ORDER: Defendants' Motion to Unredact Defendants' Opening Brief in Support of Motion Under Fed. R. Civ. P. 59 for New Trial (D.I. 989) is GRANTED as to page 2 of DTX 3221 and the corresponding portions of D.I. 885, and the last sentence of the first paragraph of page eight of D.I. 885. The Motion is DENIED as to all else. Signed by Judge Richard G. Andrews on 9/11/2019. (nms) |
| 1. | Judge Rules Against Sanofi and Regeneron in Patent Case (wsj.com) |
| Submitted Fri 01/06/2017 | |
| Docket last updated: 9 hours ago |
| Friday, April 12, 2024 | ||
| 1091 | 1091
misc
Taxation of Costs
Fri 04/12 4:06 PM
[SEALED] Clerk's Taxation of Costs in amount of $ 23,254.49 against Plaintiffs. Request for Costs1083 is GRANTED IN PART/DENIED IN PART in favor of Sanofi, Sanofi-Aventis U.S. LLC, f/d/b/a Aventis Pharmaceuticals Inc., and Regeneron Pharmaceuticals Inc. (emailed to the parties). (dmp, ) |
|